Onxeo establishes US subsidiary Onxeo establishes US subsidiary Pharmaceutical and biotech industry veteran, Philippe Maitre, will head the new venture Sanofi appoints Dr Yong-Jun Liu as Head of Research Sanofi appoints Dr Yong-Jun Liu as Head of Research He will be responsible for leading all of Sanofi's research with the goal of delivering innovative and high-value medicines for patients Quay Pharma celebrates apprentice success Quay Pharma celebrates apprentice success The firm's Apprenticeship Scheme has made an important contribution to the ongoing growth and development of its business Michael Luther joins Bantam Pharmaceutical as President and CEO Michael Luther joins Bantam Pharmaceutical as President and CEO Prior to this he was SVP and General Manager for the Discovery and Development Services Division of Albany Molecular Research Two executives join Transgene leadership team Two executives join Transgene leadership team Maud Brandely and John Felitti join the French firm Sosei appoints Peter Bains as COO and President elect Sosei appoints Peter Bains as COO and President elect He is expected to become Representative Executive Officer, President and Chief Executive at the AGM in June F-star moves into new facility in Cambridge, UK F-star moves into new facility in Cambridge, UK Also expands team with appointment of Michael Davies as VP Protein Sciences Novavax makes management promotions Novavax makes management promotions Also appoints Bob Darius as SVP, Quality Operations Kymab appoints Dr David Chiswell as Chief Executive Kymab appoints Dr David Chiswell as Chief Executive Steps up from interim CEO of the Cambridge, UK-based firm Two new appointments at BASF in the UK & Ireland Two new appointments at BASF in the UK & Ireland Richard Carter and Darren Budd take on new roles at the chemicals giant New Chief Executive and Chairman for Asterias Biotherapeutics New Chief Executive and Chairman for Asterias Biotherapeutics Stephen Cartt and Don Bailey join the US biopharmaceutical firm Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive He joins the firm to secure funding and further develop phage therapy to fight bacterial infections Ubiquigent strengthens team Ubiquigent strengthens team And enhances its drug discovery service capabilities Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Her expertise covers various infectious disease products Ideal Cures expands global reach with a presence in America Ideal Cures expands global reach with a presence in America Appoints Kamlesh Oza as President – Global Business Development New President of EMEA Operations for Astellas New President of EMEA Operations for Astellas Yukio Matsui will assume his new position on 1 April 2016